In a patient who just started amiodarone and on the same day has an elevated free thyroxine (FT4) and suppressed thyroid‑stimulating hormone (TSH), how should the hyperthyroidism be managed?

This is NOT Amiodarone-Induced Thyrotoxicosis

The abnormal thyroid function tests obtained on the same day amiodarone was started represent pre-existing hyperthyroidism that must be evaluated and managed independently of the amiodarone. Amiodarone-induced thyrotoxicosis (AIT) develops weeks to months after drug initiation, not on the same day 1.

Understanding the Timeline

Amiodarone has an extremely long half-life (averaging 58 days) and accumulates slowly in lipid-rich tissues 2. The drug's effects on thyroid function—whether causing dysfunction or simply altering thyroid function tests in euthyroid patients—occur after prolonged exposure, not immediately 3.

Your patient has coincidental hyperthyroidism that was present before amiodarone was started. The timing makes this diagnosis certain.

Immediate Management Steps

1. Identify the Cause of Hyperthyroidism

You must determine the etiology through:

• TSH receptor antibodies (TRAb) to evaluate for Graves' disease
• Thyroid ultrasound with color Doppler to assess for nodular disease, goiter, or increased vascularity
• Radioactive iodine uptake (RAIU) if diagnosis remains unclear—this will show elevated uptake in Graves' disease or toxic nodular disease, versus low uptake in thyroiditis

2. Treat According to the Underlying Cause

For Graves' disease or toxic nodular goiter:

• Start methimazole 20-40 mg daily 1
• Add beta-blocker (e.g., metoprolol or atenolol) for symptom control and cardiac protection 1

For thyroiditis (if RAIU is low):

• Beta-blocker alone for symptom management 1
• NSAIDs if painful (subacute thyroiditis)
• Corticosteroids if moderate-to-severe symptoms 1

3. Reconsider Amiodarone Use

This is critical: Starting amiodarone in a patient with active, untreated hyperthyroidism is extremely dangerous 3. The FDA label explicitly warns that amiodarone-induced hyperthyroidism "poses a greater hazard to the patient than hypothyroidism because of the possibility of thyrotoxicosis and/or arrhythmia breakthrough or aggravation, all of which may result in death" 3.

You should:

• Consult with cardiology immediately to determine if alternative antiarrhythmic therapy is available 1
• If amiodarone is the only effective option for a life-threatening arrhythmia, it may be continued, but only with aggressive treatment of the hyperthyroidism and close monitoring 1
• Achieve euthyroidism before continuing amiodarone if at all possible

Future Thyroid Monitoring

If amiodarone is continued after the pre-existing hyperthyroidism is controlled, monitor thyroid function tests at 1 month, 3 months, and then every 3-6 months 2, 1. This patient is now at risk for developing true AIT in the future, which would require differentiation between Type 1 (iodine-induced) and Type 2 (destructive thyroiditis) forms 1.

Critical Pitfall to Avoid

Do not assume these abnormal labs are an expected effect of amiodarone. While amiodarone does alter thyroid function tests in euthyroid patients (increasing T4, decreasing T3, increasing reverse T3), these changes develop gradually over weeks 3. Suppressed TSH with elevated free T4 on day one of therapy indicates pre-existing thyroid disease requiring immediate evaluation and treatment.